AXNMC(SH:600255)2025-04-29 11:53Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,023,937,586.47, representing a 13.75% increase compared to CNY 900,147,026.42 in the same period last year[2] - The net profit attributable to shareholders was CNY 8,932,145.58, a 5.42% increase from CNY 8,472,747.30 year-on-year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 32.83% to CNY 6,710,218.15 from CNY 5,051,807.90[2] - Net profit for Q1 2025 was ¥12,398,737.10, compared to ¥12,156,422.61 in Q1 2024, showing a growth of 2.0%[17] - Total comprehensive income for the period reached CNY 12,398,737.10, an increase from CNY 12,156,422.61 in the previous period[18] Cash Flow - The net cash flow from operating activities was negative at CNY -132,897,082.97, a significant decrease of 218.86% compared to CNY 111,808,652.68 in the previous year[2] - Cash inflow from operating activities totaled CNY 953,148,103.60, while cash outflow was CNY 1,086,045,186.57, resulting in a net cash flow deficit[21] - Net cash flow from operating activities in Q1 2025 was CNY 3,603,489.67, a recovery from a negative cash flow of CNY 12,510,058.18 in Q1 2024[29] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,313,302,105.33, up 2.48% from CNY 4,209,035,930.08 at the end of the previous year[3] - Total liabilities increased to CNY 1,204,732,282.53 from CNY 1,196,439,303.40, indicating a rise in financial obligations[25] - Total liabilities increased slightly to CNY 1,214,269,576.42 in 2025 from CNY 1,205,162,715.15 in 2024, reflecting a growth of approximately 0.93%[26] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 185,322[8] - The largest shareholder, Sichuan Rongxin Hongzi Technology Co., Ltd., holds 176,959,400 shares, accounting for 9.80% of total shares[8] Research and Development - Research and development expenses for Q1 2025 were ¥38,364,401.20, slightly up from ¥36,892,130.84 in Q1 2024, reflecting a 4.0% increase[17] - The company’s research and development expenses were not disclosed in the provided data, indicating a potential area for further investigation[28] Operational Strategy - The company did not report any significant new product developments or market expansion strategies during this quarter[10] - The company plans to continue focusing on improving operational efficiency and reducing costs in the upcoming quarters[29]